Shanxi Zhendong Pharmaceutical Strategic Asset Allocation Index
Shanxi Zhendong Pharmaceutical strategic asset allocation index. Shanxi Zhendong Pharmaceutical (300158) has a Strategic Asset Allocation Index of 18.9% as of June 2023. Strategic assets (PP&E of CN¥981.63 Million plus long-term investments of CN¥-) total CN¥981.63 Million, measured against net assets of CN¥5.20 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 300158 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shanxi Zhendong Pharmaceutical (2007–2022)
Strategic asset allocation index of Shanxi Zhendong Pharmaceutical from 2007 to 2022. This chart shows how Shanxi Zhendong Pharmaceutical's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of June 2023, the index stands at 18.9%, representing strategic assets of CN¥981.63 Million against net assets of CN¥5.20 Billion CNY. Check how tangible is Shanxi Zhendong Pharmaceutical's equity to evaluate the tangible quality of the company's equity base.
Shanxi Zhendong Pharmaceutical Strategic Asset Allocation Index by Year (2007–2022)
Shanxi Zhendong Pharmaceutical strategic asset allocation index by year from 2007 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shanxi Zhendong Pharmaceutical from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300158 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.3% | CN¥1.01 Billion | CN¥1.01 Billion | CN¥- | CN¥5.22 Billion | ▲ +6.3 pp |
| 2021 | 13.0% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥8.05 Billion | ▼ -3.7 pp |
| 2020 | 16.7% | CN¥943.39 Million | CN¥943.39 Million | CN¥- | CN¥5.63 Billion | ▼ -3.2 pp |
| 2019 | 19.9% | CN¥1.08 Billion | CN¥1.08 Billion | CN¥- | CN¥5.44 Billion | ▼ -0.7 pp |
| 2018 | 20.7% | CN¥1.11 Billion | CN¥1.11 Billion | CN¥1.75 Million | CN¥5.36 Billion | ▲ +0.1 pp |
| 2017 | 20.5% | CN¥1.14 Billion | CN¥1.13 Billion | CN¥13.31 Million | CN¥5.56 Billion | ▼ -1.3 pp |
| 2016 | 21.8% | CN¥1.15 Billion | CN¥1.14 Billion | CN¥12.98 Million | CN¥5.27 Billion | ▼ -33.4 pp |
| 2015 | 55.2% | CN¥1.12 Billion | CN¥1.11 Billion | CN¥12.00 Million | CN¥2.03 Billion | ▲ +3.1 pp |
| 2014 | 52.1% | CN¥1.03 Billion | CN¥1.03 Billion | CN¥- | CN¥1.97 Billion | ▼ -12.7 pp |
| 2013 | 64.7% | CN¥1.27 Billion | CN¥1.27 Billion | CN¥- | CN¥1.96 Billion | ▲ +9.6 pp |
| 2012 | 55.2% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥1.90 Billion | ▲ +24.7 pp |
| 2011 | 30.4% | CN¥565.89 Million | CN¥565.89 Million | CN¥- | CN¥1.86 Billion | ▲ +14.6 pp |
| 2010 | 15.9% | CN¥282.54 Million | CN¥282.54 Million | CN¥- | CN¥1.78 Billion | ▼ -43.9 pp |
| 2009 | 59.8% | CN¥214.69 Million | CN¥214.69 Million | CN¥- | CN¥359.31 Million | ▼ -9.2 pp |
| 2008 | 69.0% | CN¥183.98 Million | CN¥183.98 Million | CN¥- | CN¥266.72 Million | ▼ -28.2 pp |
| 2007 | 97.2% | CN¥171.48 Million | CN¥171.48 Million | CN¥- | CN¥176.42 Million | — |